Before birth, the HBG1 gene plays an important role in making gamma globin, a building block of fetal hemoglobin, which carries oxygen from the placenta to the developing baby. After birth, this job is mostly taken over by other hemoglobin genes. If HBG1 does not work as expected, fetal hemoglobin production can change, although the related HBG2 gene often shares this role. Changes affecting the HBG1 gene may also influence blood conditions such as sickle cell disease or beta thalassemia by altering fetal hemoglobin levels.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes give the directions for producing proteins, which are the parts of cells that do the work. Other genes mainly control when certain processes take place, where they happen, and how strongly they operate. Taken as a whole, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this subject more closely, you can read more in the LearnHub.
Overview
HBG1Gene function
What if the gene works
The HBG1 gene helps make gamma globin, a building block of fetal hemoglobin. This lets a baby’s blood carry oxygen efficiently before birth and during the first months of life.
Risk
What if the gene does not work
Variants in the HBG1 gene can reduce or alter one fetal hemoglobin chain. Milder variants may have little effect, while more severe variants can more clearly change how fetal hemoglobin is assembled and how strongly it binds oxygen.
Treatment
What does that mean for your treatment
No HBG1-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the HBG1 gene. The HBG1 gene is actively studied because increasing fetal hemoglobin can help in sickle cell disease and beta-thalassemia, including in drug and gene-based treatment development.
Conditions associated with HBG1
Gene function
What if the gene works
Before birth, your body uses the HBG1 gene to make part of fetal hemoglobin, the form of hemoglobin that carries oxygen in a developing baby. This helps a fetus take up oxygen from the mother's blood and move it to growing tissues. The gene is most active before birth and during the first months of life.
The HBG1 gene makes a gamma chain, one of the protein parts of fetal hemoglobin. That chain joins with alpha chains to build the hemoglobin used mainly before birth.
Fetal hemoglobin holds oxygen a little more tightly than adult hemoglobin. This helps a developing baby draw oxygen from the mother's blood through the placenta and deliver it to organs and tissues.
HBG1 stays active in newborn red blood cells for a short time after birth. This is how the HBG1 gene helps carry oxygen before birth and in early infancy, until adult hemoglobin gradually becomes the main form.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some instances, though, a variant can more significantly change how a gene functions and may play a part in a genetic condition or cause one.
Genetic variants
What if the gene does not work
HBG1 gene variants can change the fetal hemoglobin gamma chain itself or alter how much of it a cell makes. Some variants in the HBG1 gene slightly affect protein folding, stability, pairing with alpha globin, or oxygen binding, while more disruptive variants can greatly reduce gamma globin production or create an unstable hemoglobin chain. Variants in nearby control regions may also switch HBG1 activity up or down, which changes how much gamma globin is present in red blood cells.
How variants are linked to conditions
Certain rare variants in the HBG1 gene can cause hereditary persistence of fetal hemoglobin, a lifelong finding where adults keep higher fetal hemoglobin levels. This is the main way HBG1 gene variants are linked to conditions in human genetics. On its own, it often causes no health problems, but when it is inherited alongside sickle cell disease or beta thalassemia, it may be linked to a milder course.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a usual part of human biology. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant connected with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risk related to the HBG1 gene. For many living with an HBG1 change, overall risk can also depend on other genes involved in hemoglobin and on whether a blood condition is present.
Inheritance of HBG1 variants
How HBG1 gene variants are inherited is most often explained by an autosomal dominant pattern in families with hereditary persistence of fetal hemoglobin. This means one altered copy from either parent can be enough for the trait, and each child of a parent who carries the variant has a 50% chance of inheriting it. Because the HBG1 gene is on chromosome 11, sons and daughters inherit it in the same way.
What does my HBG1 result mean for my family?
There is not yet a broadly confirmed, condition-specific inheritance pattern tied to HBG1 alone. If you have a specific HBG1 result and want to know what it could mean for parents, siblings, or children, a doctor or genetic counselor can explain it in the context of your exact test finding and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for HBG1 variants usually uses a blood or saliva sample to read the HBG1 gene and look for changes linked to certain blood conditions. Results may show a benign variant, a clinically relevant variant, or no meaningful change, and are interpreted alongside blood tests and family history.
When should I consider getting a genetic test?
There is not a widely used reason to order HBG1 testing on its own. It may be considered as part of broader testing for inherited blood conditions when someone has unusual fetal hemoglobin levels, unexplained anemia, or a family history of hemoglobin conditions, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, yet how much it can tell you varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. The same treatment may work differently from one person to another because the body can absorb, break down, or respond to a drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It focuses on gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. If you want to look into this topic more closely, you can learn more in the LearnHub.
Drugs influenced by the HBG1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines or side effects are best discussed with your doctor. Researchers have studied HBG1 as part of fetal hemoglobin pathways, including whether it may relate to response to some blood condition treatments, but this has not become routine prescribing guidance.
History
Long before genes were identified, doctors noticed that newborns carry a different form of hemoglobin than older children and adults. From these first observations, research expanded steadily. In the mid 20th century, studies of fetal hemoglobin helped show that blood protein production changes with age, which became a landmark idea in human genetics. Later, researchers mapped the beta globin region on chromosome 11 and identified the HBG1 gene as one of the two closely related gamma globin genes active before birth. Work on HBG1 and its partner gene also helped explain inherited patterns in fetal hemoglobin levels. That history became especially important as scientists linked higher fetal hemoglobin to milder symptoms in some people with sickle cell disease and beta thalassemia.